1. Medtech Insight
  2. >>Business

VC Deals Analysis: Quarter-Billion Round Hikes September Takings To Five-Year High

 
• By Tina Tan

September benefitted from two nine-figure venture financing rounds, including a $250m round by consumer genetic test service provider 23andme. These bumper deals significantly boost the total takings in 2017 so far to the extent that the year looks likely to beat 2016.

Money Energy of success

Only three months left till the end of the year but 2017 looks more likely than ever to outshine 2016 as a bumper year for medtech venture fundraising. September's takings of around $820.7m, raised from the 23 medtech-related deals that disclosed financial details (there were 25 transactions in all), brought the total takings for the nine months this year to $4.99bn, less than $200m away from 2016's haul of $5.14bn.

Giving a substantial leg up to September's recorded deal value were four big-buck rounds of more than $50m, including two transactions that surpassed $100m. (See Figure 1.) There was also...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By Shubham Singh

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.